Evidence map›Paper›PMID 40882535›Full record

ArticleEpilepsy research2025

Natural history of epilepsy in FOXG1 Syndrome.

Caleb Rhodes, Benjamin Rees, Holly Dubbs, Mollie Lesser, Lucas Morgan, Tim A Benke, Alan Percy, Jeffrey L Neul, Eric D Marsh, NIH Rett and Related Disorders Natural History Study

Abstract read
In one paragraph

Article in Epilepsy research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Caleb RhodesUniversity of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
Benjamin ReesUniversity of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
Holly DubbsDivision of Child Neurology, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Mollie LesserDepartments of Pediatrics, Neurology, Pharmacology and Otolaryngology, University of Colorado School of Medicine and Children's Hospital of Colorado, Aurora, CO 80045, USA.
Lucas MorganDepartments of Pediatrics, Neurology, Pharmacology and Otolaryngology, University of Colorado School of Medicine and Children's Hospital of Colorado, Aurora, CO 80045, USA.
Tim A BenkeDepartments of Pediatrics, Neurology, Pharmacology and Otolaryngology, University of Colorado School of Medicine and Children's Hospital of Colorado, Aurora, CO 80045, USA.
Alan PercyUniversity of Alabama Birmingham, Birmingham AL, 35233.
Jeffrey L NeulVanderbilt Kennedy Center, Departments of Pediatrics, Pharmacology and Special Education, Vanderbilt University School of Medicine, Nashville, TN 37240, USA.
Eric D MarshUniversity of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA; Division of Child Neurology, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA; Departments of Neurology and Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA. Electronic address: marshe@chop.edu.
NIH Rett and Related Disorders Natural History Study

Funding

Training and Career Development ComponentU54HD061222 · NICHD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI PERCY, ALAN KENNETH · 2009 to 2019
$12.4M
Overall: Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center at VanderbiltP50HD103537 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Lea K Davis · 2020 to 2026
$10.3M
The Intellectual and Developmental Disabilities Research Center (IDDRC) at CHOP/PennP50HD105354 · NICHD · CHILDREN'S HOSP OF PHILADELPHIA · PI Michael Byrne Robinson · 2021 to 2026
$9.2M
Research Project: Sensory and Multisensory Contributions to AutismU54HD083211 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DYKENS, ELISABETH MAY · 2015 to 2019
$7.1M
NICHD NIH HHS P50 HD103537NICHD NIH HHS P50 HD105354NICHD NIH HHS U54 HD061222NICHD NIH HHS U54 HD083211
6 · The paper itself

Abstract

backgroundFOXG1 syndrome is rare neurodevelopmental disorder with microcephaly, brain malformations, epilepsy, and cognitive and motor disabilities as major features. Knowledge of the clinical features is primarily from case series and a foundation sponsored registry. We expand insight into epilepsy in FOXG1 syndrome by examining longitudinal data from 94 individuals from a multi-site natural history study and local cohorts.

methodsClinical information on severity, seizure type, and seizure features was collected from 68 individuals enrolled in the Rett Syndrome and Related Disorders Natural History Study and extracted via retrospective chart review from 15 individuals seen at the Children's Hospital of Philadelphia Rett Syndrome Center of Excellence and 11 individuals from Children's Hospital of Colorado. Genotype-phenotype and other correlations were assessed using non- and semi-parametric analyses.

results78.7 % of participants had seizures, beginning at a median age of 1.0 years. Individuals were followed for a median of 4.9 years after first seizure onset. Taken independently, over 70 % of seizures were partial or tonic-clonic, occurred less than weekly, and lasted less than 5 min. 1/3 of seizures resolved in a median time and age of 1.1 and 3.3 years. Age had a weak non-linear association with average seizure frequency, and, for those with seizures, smaller head circumference correlated with increased disease severity.

conclusionsWe further characterize disease severity and epilepsy in FOXG1 syndrome and demonstrate that smaller head circumferences are associated with more severe disease and age is weakly non-linearly correlated with average seizure frequency. This information will improve clinical care and aid therapeutic development.

Indexed as

EpilepsyForkhead Transcription FactorsNerve Tissue ProteinsRett SyndromeAdolescentAdultChildChild, PreschoolFemaleHumansInfantLongitudinal StudiesMaleMicrocephalyRetrospective StudiesYoung AdultForkhead Transcription FactorsFOXG1 protein, humanNerve Tissue ProteinsDevelopmental EncephalopathyEpilepsyFOXG1FOXG1 SyndromeSeizure

Identifiers

PMID40882535
PMCPMC12481521

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.